CONCURRENT TARGETING OF ONCOGENIC PATHWAYS TO ENHANCE CHEMOTHERAPY AND IMMUNOTHERAPY
The present invention relates to the field of cancer. More specifically, the present invention provides compositions and methods for treating cancer by targeting YAP1 and STAT3 pathways. In a specific embodiment, the present invention provides a method for increasing sensitivity of cancer in a subje...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
05.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The present invention relates to the field of cancer. More specifically, the present invention provides compositions and methods for treating cancer by targeting YAP1 and STAT3 pathways. In a specific embodiment, the present invention provides a method for increasing sensitivity of cancer in a subject to chemotherapy and/or immunotherapy comprising the step of administering to the subject an effective amount of a YAP1 inhibitor and a STAT3 inhibitor. |
---|---|
Bibliography: | Application Number: EP20220850563 |